Skip to main content
Log in

Early detection of speech and voice disorders in Parkinson’s disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

We previously reported that Parkinson’s disease (PD) patients treated with subthalamic nucleus deep brain stimulation (STN-DBS) had distinct phenotypes of speech and voice disorders: hypokinetic dysarthria, stuttering, breathy voice, strained voice, and spastic dysarthria. However, changes over time remain unclear. In the present study, 32 consecutive PD patients were assessed before and up to 1 year after surgery (PD-DBS). Eleven medically treated PD patients were also assessed (PD-Med). Speech, voice, motor, and cognitive functions were evaluated. At baseline, the incidence of hypokinetic dysarthria (63% of PD-DBS vs. 82% of PD-Med), stuttering (50% vs. 45%), breathy voice (66% vs. 73%), and strained voice (3% vs. 9%) was similar between groups. At 1 year, a slight but significant deterioration in speech intelligibility (p < 0.001) and grade of dysphonia (p = 0.001) were observed only in PD-DBS group compared with baseline. During the follow-up, stuttering (9% vs. 18%) and breathy voice (13% vs. 9%) emerged in PD-DBS and PD-Med, but strained voice (28%) and spastic dysarthria (44%) emerged only in PD-DBS. After the stimulation was stopped, strained voice and spastic dysarthria improved in most patients, while stuttering and breathy voice improved in a minority of patients. These findings indicate that the most common DBS-induced speech and voice disorders are strained voice and spastic dysarthria and that STN-DBS potentially aggravates stuttering and breathy voice. An improved understanding of these types of disorders may help detect speech and voice deteriorations during the early phase and lead to appropriate treatments.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aldridge D, Theodoros D, Angwin A et al (2016) Speech outcomes in Parkinson’s disease after subthalamic nucleus deep brain stimulation: a systematic review. Parkinsonism Relat Disord 33:3–11

    Article  PubMed  Google Scholar 

  • Alm PA (2004) Stuttering and the basal ganglia circuits: a critical review of possible relations. J Commun Disord 37:325–369

  • Atkinson-Clement C, Sadat J, Pinto S (2015) Behavioral treatments for speech in Parkinson’s disease: meta-analyses and review of the literature. Neurodegener Dis Manag 5:233–248

    Article  PubMed  Google Scholar 

  • Benke T, Hohenstein C, Poewe W et al (2000) Repetitive speech phenomena in Parkinson’s disease. J Neurol Neurosurg Psychiatry 69:319–325

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Burghaus L, Hilker R, Thiel A et al (2006) Deep brain stimulation of the subthalamic nucleus reversibly deteriorates stuttering in advanced Parkinson’s disease. J Neural Transm 113:625–631

    Article  CAS  PubMed  Google Scholar 

  • D’Alatri L, Paludetti G, Contarino M et al (2008) Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice 22:365–372

    Article  PubMed  Google Scholar 

  • Darley FL, Aronson AE, Brown JR (1969) Differential diagnostic patterns of dysarthria. J Speech Hear Res 12:246–269

    Article  CAS  PubMed  Google Scholar 

  • Deuschl G, Schade-Brittinger C, Krack P et al (2006) A randomized trial of deep-brain stimulation for Parkinson’s disease. N Engl J Med 355:896–908

    Article  CAS  PubMed  Google Scholar 

  • di Biase L, Fasano A (2016) Low-frequency deep brain stimulation for Parkinson’s disease: great expectation or false hope? Mov Disord 31:962–967

    Article  PubMed  Google Scholar 

  • Fenoy AJ, McHenry MA, Schiess MC (2017) Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract. J Neurosurg 126:2017–2027

    Article  PubMed  Google Scholar 

  • Goberman A, Blomgren M, Metzger E (2010) Characteristics of speech disfluency in Parkinson disease. J Neurolinguistics 23:470–478

    Article  Google Scholar 

  • Hartmann CJ, Wojtecki L, Vesper J et al (2015) Long-term evaluation of impedance levels and clinical development in subthalamic deep brain stimulation for Parkinson’s disease. Parkinsonism Relat Disord 21:1247–1250

    Article  CAS  PubMed  Google Scholar 

  • Hirano M (1981) Clinical examination of voice. Springer-Verlag, New York

    Google Scholar 

  • Ho AK, Iansek R, Bradshaw JL (1998) Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol 11:131–137

    Article  PubMed  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Klostermann F, Ehlen F, Vesper J et al (2008) Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 79:522–529

    Article  CAS  PubMed  Google Scholar 

  • Nishio M (2004) Assessment of motor speech for dysarthria. Interuna Publishers, Tokyo

    Google Scholar 

  • Picillo M, Lozano AM, Kou N et al (2016) Programming deep brain stimulation for Parkinson’s disease: the Toronto Western Hospital Algorithms. Brain Stimul 9:425–437

    Article  PubMed  Google Scholar 

  • Pinto S, Ozsancak C, Tripoliti E et al (2004) Treatments for dysarthria in Parkinson’s disease. Lancet Neurol 3:547–556

    Article  PubMed  Google Scholar 

  • Plaha P, Ben-Shlomo Y, Patel NK et al (2006) Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 129:1732–1747

    Article  PubMed  Google Scholar 

  • Sapir S (2014) Multiple factors are involved in the dysarthria associated with Parkinson’s disease: a review with implications for clinical practice and research. J Speech Lang Hear Res 57:1330–1343

    Article  PubMed  Google Scholar 

  • Schaltenbrand G, Wahren W (1977) Atlas for stereotaxy of the human brain, 2nd edn. Thieme, Stuttgart

    Google Scholar 

  • Suzuki J, Tanaka Y, Watanabe H et al (2013) A case of Parkinson’s disease treated effectively with a pacing board for repetitive speech phenomena after deep brain stimulation. Rinsho Shinkeigaku 53:304–307

    Article  PubMed  Google Scholar 

  • Tanaka Y, Tsuboi T, Watanabe H et al (2015) Voice features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Neurol 262:1173–1181

    Article  PubMed  Google Scholar 

  • Tanaka Y, Tsuboi T, Watanabe H et al (2016) Articulation features of Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. J Park Dis 6:811–819

    Article  Google Scholar 

  • Tomlinson CL, Stowe R, Patel S et al (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25:2649–2653

    Article  PubMed  Google Scholar 

  • Tommasi G, Krack P, Fraix V et al (2008) Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 79:813–819

    Article  CAS  PubMed  Google Scholar 

  • Tripoliti E, Zrinzo L, Martinez-Torres I et al (2011a) Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 76:80–86

    Article  CAS  PubMed  Google Scholar 

  • Tripoliti E, Strong L, Hickey F et al (2011b) Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson’s disease. Mov Disord 26:2434–2436

    Article  PubMed  PubMed Central  Google Scholar 

  • Tripoliti E, Limousin P, Foltynie T et al (2014) Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson’s disease. Mov Disord 29:532–538

    Article  CAS  PubMed  Google Scholar 

  • Tsuboi T, Watanabe H, Tanaka Y et al (2015a) Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry 86:856–864

    Article  PubMed  Google Scholar 

  • Tsuboi T, Watanabe H, Tanaka Y et al (2015b) Characteristic laryngoscopic findings in Parkinson’s disease patients after subthalamic nucleus deep brain stimulation and its correlation with voice disorder. J Neural Transm 122:1663–1672

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by JSPS KAKENHI Grant Number JP16K19507.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gen Sobue.

Ethics declarations

Conflicts of interest

Nothing to report.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 341 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tsuboi, T., Watanabe, H., Tanaka, Y. et al. Early detection of speech and voice disorders in Parkinson’s disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study. J Neural Transm 124, 1547–1556 (2017). https://doi.org/10.1007/s00702-017-1804-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-017-1804-x

Keywords

Navigation